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Abstract. 
 
The E5 oncoprotein of bovine papillomavi-
rus type I is a small, hydrophobic polypeptide localized 
predominantly in the Golgi complex. E5-mediated 
transformation is often associated with activation of the 
PDGF receptor (PDGF-R). However, some E5 mu-
tants fail to induce PDGF-R phosphorylation yet retain 
transforming activity, suggesting an additional mecha-
nism of action. Since E5 also interacts with the 16-kD 
 
pore-forming subunit of the vacuolar H
 
1
 
-ATPase
(V-ATPase), the oncoprotein could conceivably inter-
fere with the pH homeostasis of the Golgi complex. A 
pH-sensitive, ﬂuorescent bacterial toxin was used to la-
bel this organelle and Golgi pH (pH
 
G
 
) was measured 
by ratio imaging. Whereas pH
 
G
 
 of untreated cells was 
acidic (6.5), no acidiﬁcation was detected in E5-trans-
 
fected cells (pH 
 
z
 
7.0). The Golgi buffering power and 
the rate of H
 
1
 
 leakage were found to be comparable in 
control and transfected cells. Instead, the E5-induced 
pH differential was attributed to impairment of
V-ATPase activity, even though the amount of ATPase 
present in the Golgi complex was unaltered. Mutations 
that abolished binding of E5 to the 16-kD subunit or 
that targeted the oncoprotein to the endoplasmic retic-
ulum abrogated Golgi alkalinization and cellular trans-
formation. Moreover, transformation-competent E5 
mutants that were defective for PDGF-R activation al-
kalinized the Golgi lumen. Neither transformation by 
sis
 
 
 
nor src, two oncoproteins in the PDGF-R signaling 
pathway, affected pH
 
G
 
. We conclude that alkalinization 
of the Golgi complex represents a new biological activ-
ity of the E5 oncoprotein that correlates with cellular 
transformation.
Key words: vesicular trafﬁc • pH regulation • cholera 
toxin • proton pump • V-ATPase
 
Introduction
 
Papillomaviruses (PVs)
 
1
 
 are small, double-stranded DNA
viruses that infect a wide range of vertebrate species and
induce papillomas of squamous epithelia (zur Hausen,
1989; Band et al., 1990). In humans, a specific subset of
PVs are associated with the progression of squamous le-
sions to dysplasia and carcinoma (Orth, 1987; zur Hausen
and Schneider, 1987). In most cases, the papillomaviruses
contain three transforming genes: E5, E6, and E7.
The bovine papillomavirus (BPV-1) E5 protein was one
of the first PV oncoproteins to be identified (Schlegel et al.,
1986). To date, it is still the best characterized E5 oncopro-
tein since the E5 proteins of the human papillomaviruses
have been notoriously difficult to detect and study in vitro.
The E5 protein of BPV is a highly hydrophobic, type II
membrane protein of 44 amino acids, which is predomi-
nantly expressed in the Golgi complex as a homodimer
(Horwitz et al., 1988; Burkhardt et al., 1989). The COOH
terminus of E5 consists of a 14–amino acid hydrophilic
domain that extends into the Golgi lumen; this domain
contains two highly conserved cysteine residues that form
disulfide bonds and stabilize homodimer formation. The
hydrophobic NH
 
2
 
 terminus of E5 contains 30 amino acids
that are predicted to be in 
 
a
 
-helical conformation and
serve as a transmembrane domain (Horwitz et al., 1988).
Interestingly, it is this transmembrane domain which
mediates the physical interaction of E5 with two cellu-
lar proteins: the platelet-derived growth factor receptor
 
(PDGF-R) and the 16-kD subunit of the vacuolar H
 
1
 
-ATP-
ase (V-ATPase; Goldstein and Schlegel, 1990; Goldstein
et al., 1991, 1992a; Petti and DiMaio, 1992, 1994).
The mechanism whereby E5 mediates transformation of
the host cells has not been completely elucidated. Immu-
noprecipitation studies have demonstrated that the on-
coprotein can bind and induce autophosphorylation of
PDGF-R in several cell lines (Petti et al., 1991; Petti and
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DiMaio, 1992; Goldstein et al., 1994; Drummond-Barbosa
et al., 1995). Binding to PDGF-R appears to involve a hy-
drophilic glutamine residue in the E5 transmembrane do-
main (Sparkowski et al., 1996). A transformation mecha-
nism has been proposed in which binding of the dimeric
form of E5 to PDGF-R results in dimerization and
transphosphorylation of the receptor, resulting in continu-
ous mitogenic signaling and cell transformation. Indeed,
recent results indicate that dimerization of E5 is critical for
PDGF-R activation (Adduci and Schlegel, 1999). How-
ever, mutagenesis studies have also shown that the ability
of E5 to activate the PDGF-R can be dissociated from its
transforming ability. Several highly transforming mutants
of E5 fail to induce autophosphorylation of PDGF-R in fi-
broblasts (Sparkowski et al., 1996; Adduci and Schlegel,
1999), suggesting that E5 has at least one alternative path-
way to cell transformation. This possibility may also ac-
count for the finding that E5 is capable of transforming ke-
ratinocytes that lack detectable PDGF-R (Leptak et al.,
1991).
In addition to the PDGF-R, the E5 oncoprotein has also
been shown to associate with a 16-kD hydrophobic pro-
tein, subsequently identified as the 16-kD subunit of the
V
 
0
 
 moiety of the V-ATPase (Goldstein et al., 1991). Six
copies of the 16-kD subunit assemble to form an H
 
1
 
-selec-
tive pore across the membrane bilayer (Sun et al., 1987;
Mandel et al., 1988; Forgac, 1992), and the complete en-
zyme complex is responsible for acidifying the lumen of
many endomembrane organelles, including the Golgi com-
plex (Forgac, 1989). Therefore, it is conceivable that the
association of E5 with this 16-kD subunit might interfere
with H
 
1
 
 translocation through the V-ATPase and, conse-
quently, with organellar acidification. Since E5 is predomi-
nantly localized in the Golgi complex, the pH of this
compartment would be particularly affected by the onco-
protein, potentially altering the targeting, processing, and
turnover of many regulatory proteins that are processed in
this compartment.
To test the hypothesis that E5 might alter V-ATPase
function, measurements were made of the luminal pH of
the Golgi complex (pH
 
G
 
) in control and E5-transformed
cells using ratio imaging of Golgi-targeted, H
 
1
 
-sensitive
probes. These in situ measurements were accomplished by
harnessing an endogenous retrograde pathway of the cells
that delivers surface glycolipids to the Golgi complex
(Schapiro et al., 1998). Nontoxic B subunits of cholera
toxin, which bind avidly and specifically to cell surface gly-
colipids (monogangliosides), were conjugated to fluores-
cent H
 
1
 
-sensitive probes, bound to the cell surface, and al-
lowed to translocate to the Golgi complex. Spectroscopic
measurements of pH
 
G
 
 were performed in living cells by
fluorescence ratio imaging. Our results indicate that the
E5 oncoprotein impairs acidification of the lumen of the
Golgi complex, and that inhibition of the V-ATPase ac-
counts for the observed effects.
 
Materials and Methods
 
Reagents and Antibodies
 
FITC-labeled CTB and ATP were purchased from Sigma Chemical Co.
BSA (fraction V) was purchased from Boehringer Mannheim. Butyric
 
acid was from J.T. Baker and trimethylamine from Aldrich Chemical Co.
Polyclonal antibodies to the 39-kD subunit of the V-ATPase were raised
in rabbits injected with a fusion protein encoding the entire bovine sub-
unit. The polyclonal antibody to 
 
a
 
-mannosidase II was a gift of Dr. M.
Farquhar (University of California at San Diego, San Diego, CA) and the
mAb to the AU1 epitope was from the Berkeley Antibody Company. A
mouse mAb to GM130 was from Transduction Laboratories. Cy3-labeled
donkey anti–mouse and donkey anti–rabbit antibodies were from Jackson
ImmunoResearch Laboratories, Inc. Nigericin was from Molecular
Probes, Inc. and concanamycin A from Kamiya Biochemical Company.
Lyophilized streptolysin O was provided by Dr. S. Bhakdi (Johannes-
Gutenberg Universitat, Mainz, Germany) and dissolved in modified Dul-
becco’s buffered saline solution (PBS; Pierce Chemical Co.) at 1 mg/ml
and stored at 
 
2
 
80
 
8
 
C. Immediately before use, streptolysin O was diluted
in permeabilization buffer containing 2 mM DTT to a final concentration
of 0.2 
 
m
 
g/ml. NIH-3T3 cells were from the American Tissue Culture Col-
lection. Cell culture media and antibiotics were from GIBCO BRL. All
other chemicals and reagents were of the highest purity available.
 
Solutions
 
The calibration KCl-rich solution contained (in mM): 140 KCl, 10 glucose,
10 Hepes, 10 MES, 1 CaCl
 
2
 
, and 1 MgCl
 
2
 
 (pH ranged from 6 to 7). The
permeabilization buffer consisted of (in mM) 90 potassium glutamate, 50
KCl, 10 NaCl, 1 MgCl
 
2
 
, 2 CaCl
 
2
 
, 4 EGTA, 2 K
 
2
 
HPO
 
4
 
, 20 Hepes, 4 ATP, 3
sodium pyruvate, and 1 mg/ml BSA, pH 7.2.
 
Plasmid Constructions, Cell Culture, and Cell Lines
 
Construction of the expression vector pJS55, a modified pSG5 plasmid
(Stratagene), and corresponding E5 mutants has been described previ-
ously (Sparkowski et al., 1994). These constructs were used for generat-
ing stable NIH-3T3 E5-expressing cell lines as described previously
(Sparkowski et al., 1996). Stably transfected NIH-3T3 cells were cultured
at 37
 
8
 
C in DME containing 10% heat-inactivated FBS (Cansera Interna-
tional, Inc.), 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin under 5%
CO
 
2
 
. For immunofluorescence and ratio imaging, cells were plated onto
18- or 25-mm glass coverslips in 6-well plastic culture dishes 24 h before
the experiments. Experiments were performed when cells reached 
 
z
 
60–
70% confluence.
 
Fractionation and Immunoblotting
 
Purification of the Golgi complex was performed by the method of Beck-
ers and Rothman (1992). In brief, cells grown to near confluence in seven
15-cm plates were detached, washed, and resuspended in 6 ml of 250 mM
sucrose, 10 mM Tris-HCl, pH 7.4 with 1 mM phenylmethylsulfonyl chlo-
ride. The cells were lysed by 
 
z
 
30 strokes of a Dounce homogenizer with a
tight pestle, and the lysate was mixed with 5.5 ml of 62% sucrose in 10 mM
Tris-HCl, pH 7.4 plus 230 
 
m
 
l of 0.1 M EDTA. Of this mixture, 5.6 ml were
placed at the bottom of a 12-ml polycarbonate tube and overlaid with lay-
ers of 35 and 29% sucrose in Tris-HCl. The samples were subjected to
centrifugation for 2.5 h at 25,700 rpm in a Beckman SW41 rotor and Golgi
membranes were collected from the 35–29% interface by puncturing the
side of the tube. The sample was diluted into 10 ml of PBS and sedi-
mented before determination of protein content and electrophoresis.
For immunoblotting, the samples were analyzed by SDS-PAGE on
10% acrylamide gels, and blotted onto nitrocellulose. After blocking, the
blot was incubated with either a 1:1,000 dilution of anti–V-ATPase anti-
body or 1:250 of anti-GM130. After washing, the blots were exposed to a
1:2,000 dilution of HRP-conjugated secondary anti–rabbit or anti–mouse
antibodies, respectively. Immunoreactive bands were visualized by en-
hanced chemiluminescence (Amersham).
 
Immunoprecipitation
 
Cell lines were plated on 100-mm dishes and allowed to grow to 
 
z
 
80%
confluency in DME. Cells were washed once with PBS and incubated with
2 ml methionine- and cysteine-free DME, and 0.5 mCi [
 
35
 
S]methionine
(Pro Mix; Amersham). Plates were incubated at 37
 
8
 
C with rocking for 3 h.
Labeled cells were placed on ice, aspirated of medium, and washed once
with cold PBS. Cells were lysed in 1 ml of a modified RIPA buffer (20 mM
morpholine propanesulfonic acid, 150 mM NaCl, 1 mM EDTA, 1% NP-
40, 1% deoxycholate, and 0.1% SDS) by scraping into microcentrifuge
tubes. Lysates were vortexed for 2 min and clarified by centrifugation. 4
 
m
 
l of the mAb, AU1 (Goldstein et al., 1992b), and 50 
 
m
 
l of protein 
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A–Sepharose beads (Pierce Chemical Co.) were added to supernatants
followed by incubation at 4
 
8
 
C for 90 min. Beads were subjected to three
washes with lysis buffer and one wash with PBS. Samples were eluted with
sample buffer plus 10% 
 
b
 
-mercaptoethanol, boiled for 4 min, and loaded
onto 14% polyacrylamide gels for protein separation. Gels were fixed in
30% methanol, 10% acetic acid for 10 min, dried, and exposed to Kodak
Biomax MS film.
 
Immunocytochemistry and Fluorescence Microscopy
 
Cells were fixed in 4% paraformaldehyde in PBS at room temperature for
30 min, washed with 100 mM glycine, and permeabilized with 0.1% Triton
X-100 in PBS. Fixed and permeabilized cells were blocked with 5% don-
key serum in PBS containing 0.1% BSA and 0.1% Triton X-100 for 20 min
at room temperature, washed three times with PBS, and incubated with
anti–AU1 antibody (1:800 dilution in PBS containing 0.1% BSA and 0.1%
Triton X-100) and anti–
 
a
 
-mannosidase II antibody (1:500 dilution in PBS
containing 0.1% BSA and 0.1% Triton X-100) for 2 h at room tempera-
ture. Samples were subsequently washed three times in PBS containing
0.1% BSA and incubated with Cy3-labeled donkey anti–mouse antibody
and FITC-labeled donkey anti–rabbit antibody (1:1,000 dilution in PBS
containing 0.1% BSA and 0.1% Triton X-100) for 1 h at room tempera-
ture. After washing three times in PBS with 0.1% BSA, samples were
treated with Dako fluorescence mounting medium. Control experiments
were performed omitting the primary antibody (not shown).
Analysis of the samples was performed using the 100
 
3
 
 objective of a
Leica DM1RB fluorescence microscope equipped with a Micromax
cooled CCD camera (Princeton Instruments), operated from a Dell com-
puter using Winview software (Princeton Instruments). Digitized images
were cropped in Adobe Photoshop (Adobe Systems, Inc.) and imported
to Microsoft PowerPoint for assembly and labeling. All images are repre-
sentative of at least three separate experiments.
 
Toxin Labeling and pH
 
G
 
 Imaging
 
Cells were washed three times in cold PBS containing 1 mM CaCl
 
2
 
 and
1 mM MgCl
 
2
 
, pH 7.4, and then preincubated with 10 
 
m
 
g/ml of FITC-CTB
in PBS for 1 h at 4
 
8
 
C to promote binding to the plasmalemmal receptors
without endocytosis. After washing twice with PBS, internalization was
initiated by incubating the cells at 37
 
8
 
C for 2 h in DME.
For imaging experiments, FITC-CTB–labeled cells grown on 25-mm
diam glass coverslips were inserted into a Leiden CoverSlip Dish (Medical
Systems Corp.), which was in turn placed into a thermostatted perfusion
chamber (Open Perfusion Micro-Incubator; Medical Systems Corp.) on
the stage of an inverted microscope (Zeiss Axiovert 135; Oberkochen)
equipped with a 63
 
3
 
 oil immersion objective and epifluorescence optics.
An electronically controlled shutter and filter-wheel (Sutter Instruments
Co.) was used to alternately position two excitation filters (490BP10 and
440BP10 nm) in front of a 75-W xenon lamp, whereas continuous 620-nm
illumination was provided by a filtered incandescent light source. The ex-
citation light was directed via a 510-nm dichroic mirror, whereas the emit-
ted fluorescence (
 
.
 
510 nm) and the transmitted red light (
 
.
 
620 nm) were
separated by a 580-nm emission dichroic mirror. The red light was di-
rected to a video camera for continuous visualization of the cells, whereas
the fluorescent signals were processed through a 535BP25-nm band-pass
filter. Digitized images were captured on a frame transfer air-cooled CCD
camera (Princeton Instruments Inc.). Data were recorded every 30 or 60 s
by irradiating the cells for 1 s at each wavelength using 4 
 
3 
 
4 pixel binning.
Control of image acquisition was achieved using Metafluor software (Uni-
versal Imaging Corp.), operating on a Pentium Dell computer. Regions of
interest were selected for measurement by the imaging system. Back-
ground fluorescence was subtracted off line for each wavelength.
At the end of each experiment, a calibration curve of fluorescence ver-
sus pH was obtained in situ by two independent methods. Nigericin cali-
bration was achieved by sequentially perfusing the cells with KCl-rich me-
dia buffered to pH values ranging from 5.5 to 7.0 in the presence of 5 
 
m
 
M
nigericin. Approximately 3 min were allowed for equilibration at each pH.
This calibration procedure was validated by the null point method (Eisner
et al., 1989) using solutions containing varying ratios of butyric acid and
trimethylamine, plus 50 mM NaCl and 20 mM Hepes, pH 7.2.
 
Data Analysis
 
Quantification of cell-associated fluorescence was performed using Meta-
morph/Metafluor software (Universal Imaging). Data were plotted using
 
the Origin software (MicroCal Software Inc.), and are representative of at
least four separate experiments of each type.
 
Results
 
Expression and Subcellular Localization of E5 in
NIH-3T3 Cells
 
To evaluate the effect of E5 on Golgi V-ATPase activity,
we generated cell lines that stably expressed the oncopro-
tein. Plasmid DNA encoding E5 was cotransfected into
NIH-3T3 cells simultaneously with a plasmid conferring
neomycin resistance, and cells were selected using G418 as
described in Materials and Methods. Pooled colonies of
G418-resistant cells were expanded and used for biochem-
ical analysis. The E5 oncoprotein was tagged at its NH
 
2
 
terminus with a 6–amino acid epitope (AU1), to allow for
efficient detection by immunofluorescence and immuno-
precipitation (Sparkowski et al., 1994).
The expression of E5 in the stable transfectants and its
subcellular localization were verified by immunoprecipita-
tion (see below) and immunofluorescence microscopy us-
ing the AU1 antibody. As shown in Fig. 1, the oncoprotein
was found to concentrate in a compact juxtanuclear struc-
ture (a similar pattern was observed in two separate clonal
cell lines). No staining was observed in NIH-3T3 cells sta-
bly transfected with the empty vector (not shown), validat-
ing the specificity of the immunolabeling reaction. The
juxtanuclear structure where E5 was concentrated was
found to colocalize with the Golgi marker 
 
a
 
-mannosidase
II (Fig. 1 A) confirming that, as reported earlier (Gold-
stein and Schlegel, 1990), the E5 oncoprotein accumulates
in the Golgi cisternae. The distribution of 
 
a
 
-mannosidase
II in control and E5-transfected cells was similar, implying
that the oncoprotein does not alter Golgi morphology.
 
Measurement of Golgi pH (pH
 
G
 
)
 
We next studied whether the interaction between E5 and
the 16-kD subunit of the V-ATPase resulted in alterations
of the pH of the Golgi complex (pH
 
G
 
). To measure pH
 
G
 
,
the lumen of the Golgi complex of intact cells was labeled
with a fluorescent pH-sensitive probe. This was accom-
plished by incubating the cells with FITC-CTB, the non-
toxic receptor subunit of cholera toxin, which binds to
monogangliosides at the cell surface and is subsequently
transported via a retrograde pathway to the Golgi (Scha-
piro et al., 1998). Cells were preincubated with the labeled
toxin at 4
 
8
 
C for 1 h, washed, and incubated for two addi-
tional hours at 37
 
8
 
C to allow internalization and transport
to the Golgi complex. The accumulation of CTB in the
Golgi cisternae was verified by its colocalization with
 
a
 
-mannosidase II (not shown). To confirm that the onco-
protein and the probe were present in the same compart-
ment, the distribution of the former was assessed by
immunofluorescence using a Cy3-conjugated secondary
antibody, whereas FITC-CTB could be visualized directly.
As shown in Fig. 1, C and D, the pH-sensitive toxin colo-
calizes precisely with E5. As found for mannosidase, the
subcellular distribution of CTB was not affected by the ex-
pression of E5. These observations demonstrate that
FITC-CTB is appropriate for probing the pH of the com-
partment occupied by E5. 
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pH
 
G
 
 was measured by fluorescence ratio imaging. Im-
ages of labeled cells were acquired sequentially with exci-
tation at 490 and 440 nm, while measuring the emission at
535 nm. The ratio of the fluorescence recorded at the two
excitation wavelengths was calibrated aposteriori in each
individual experiment, as shown in Fig. 2. Calibrations
were initially performed using the K
 
1
 
/H
 
1
 
 ionophore ni-
gericin while bathing the cells in KCl-rich media of varying
pH. As described earlier for other cells (Kim et al., 1996;
Kneen et al., 1998; Llopis et al., 1998), the resting pH
 
G
 
 of
untransfected NIH-3T3 cells was acidic (Fig. 2 A). In four
determinations, pH
 
G
 
 averaged 6.48 
 
6 
 
0.03. Strikingly, the
basal pH
 
G
 
 of E5-transfected cells was consistently more al-
kaline, averaging 6.97 
 
6 
 
0.06 in four determinations (Fig. 2
B). Analysis by Student’s 
 
t
 
 test for unpaired samples indi-
cated that the difference is highly significant (
 
P
 
 , 
 
0.01).
Calibration using exchange ionophores assumes that the
monovalent cation activity in the Golgi complex and the
surrounding medium are similar, and that the amount of
K
 
1
 
 transported during the transition between pH values
does not affect its concentration significantly. Because the
monovalent ion activity of the Golgi complex has not been
reported, the absolute pH values estimated could poten-
tially be inaccurate. More importantly, it is conceivable
that the apparent difference in pH
 
G
 
 between normal and
E5-transfected cells may be artifactual, resulting from dif-
ferences in their cationic content. For these reasons, a sec-
ond calibration procedure was implemented. We chose the
Figure 1. Subcellular localization of E5. (top)
NIH-3T3 cells that were stably transfected with
AU1-tagged E5 were fixed, permeabilized, and
immunostained with anti–a-mannosidase II anti-
bodies (1:500; A) and anti–AU1 antibodies (1:
800; B). (bottom) E5-transfected cells were prein-
cubated at 48C for 1 h with 10 mg/ml FITC-CTB,
followed by a 2-h chase at 378C. The cells were
fixed, permeabilized, and immunostained with
anti–AU1 antibodies (1:800) followed by a Cy3-
conjugated secondary antibody (D). The distri-
bution of FITC-CTB is shown in C. Fluorescence
images were captured as described in Materials
and Methods and are representative of at least
three experiments.
Figure 2. In situ measurements of pHG. Control
(A and C) and E5-transfected cells (B and D)
were labeled with FITC-CTB as described in Ma-
terials and Methods. Fluorescence images were
acquired sequentially with excitation at 490 and
440 nm and the ratio of the emission (ordinate)
calculated after off-line background subtraction.
(A and B) After acquiring basal readings, nigeri-
cin was added in KCl-rich solutions of the indi-
cated pH. (C and D) After acquiring basal read-
ings, pHG was estimated by the null-point
method, by perfusing the sample with solutions
of pH 7.3 containing varying concentrations of
butyrate and trimethylamine. The pHG at which
each solution is predicted to equilibrate (i.e., pro-
duce no net change in pH) is indicated. The ra-
tios of butyrate to trimethylamine used, calcu-
lated according to Eisner et al. (1989), were as
follows: 0.25:1 for pH 7.6; 1:1 for pH 7.3; 1.6:1 for
pH 7.2; 10:1 for pH 6.8; 16:1 for pH 6.7; and 100:1
for pH 6.3. Data are representative of four simi-
lar experiments. 
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null-point method, which can assign an absolute value of
pH
 
G
 
 without requiring assumptions regarding the mono-
valent ion composition. In this approach, various ratios of
weak acids and bases are used to search for a null point
where the rates of protonation/deprotonation of the per-
meable species of the electrolytes are identical (Eisner et al.,
1989). For a given combination of acid and base, the null
point is strictly a function of the luminal pH. Using this cal-
ibration method, we determined that pH
 
G
 
 equals 6.51
 
 6
 
0.05 for control cells and 7.01
 
 6 
 
0.03 for E5-transfected
cells (Fig. 2, C and D, respectively), in good agreement
with the determinations made using nigericin calibration.
Similar results were obtained with both methods using a
second clone of E5-transfected cells (not shown). To-
gether, these results indicate that the expression of the E5
oncoprotein is associated with defective acidification of
the Golgi complex.
 
Effect of Concanamycin on pH
 
G 
 
in Control and
E5-transfected Cells
 
In several cell types, acidification of the luminal fluid of
the Golgi complex is accomplished by active pumping of
H
 
1
 
 by V-ATPases (Lowe and Al-Awqati, 1988; Moriyama
et al., 1989; Kim et al., 1996). As illustrated in Fig. 3, a sim-
ilar mechanism is responsible for the acidification of pH
 
G
 
in control NIH-3T3 cells. This conclusion was based upon
the effects of concanamycin, which rapidly dissipated the
acidification of the Golgi complex in these cells. At the
concentration used (100 nM), concanamycin specifically
inhibits V-ATPases, without any reported effects on other
systems (Bowman et al., 1988). Importantly, addition of
concanamycin had only a minute effect on pH
 
G
 
 in E5-
transfected cells (Fig. 3).
The failure of concanamycin to alter pH
 
G
 
 in E5-trans-
fectants suggests that H
 
1
 
 pumping is greatly reduced in
these cells. In principle, this could be attributed to the fol-
lowing: (1) a change in the number or intrinsic activity of
V-ATPases; (2) a decreased counterion permeability, which
in turn would limit the rate of electrogenic pumping; (3) a
large H
 
1
 
 leak in the Golgi membrane; or (4) an inor-
dinately large H
 
1
 
 buffering capacity of Golgi luminal
contents. These possibilities were analyzed individually
below.
 
The Buffering Power of the Golgi Complex Is Not 
Affected by E5
 
While the rate of acidification depends on Golgi buffering
power, the final pH of a closed system at equilibrium
would not be expected to vary. However, it must be con-
sidered that the Golgi complex is in a rapid state of flux,
with vesicles being incorporated continuously on the cis
side and budding off the trans side. The steady state pH of
such an open system varies as a function of its buffering
capacity. Therefore, we considered the possibility that ex-
pression of E5, which is greatly accumulated in the Golgi
complex, might significantly increase luminal buffering
power and minimize acidification by a limited number of
proton pumps over a finite period of time.
The buffering power, which is a function of the concen-
tration of titratable groups and of their pK, can vary with
pH. To appropriately compare the buffering power of con-
 
trol and transfected cells, the measurements were per-
formed at the same pH
 
G
 
. This was accomplished by ini-
tially dissipating the acidification of the Golgi of control
cells with concanamycin (Fig. 3 B). The drug was also
added to the E5 cells to maintain identical conditions. The
buffering power was assessed by pulsing with a permeable
weak base (NH
 
3
 
; Fig. 3 B) as described by Roos and Bo-
ron (1981). Data of three similar experiments, summarized
in the inset to Fig. 3 B, demonstrated that the buffering
power of the Golgi of control and E5-expressing NIH-3T3
cells, measured at pH 6.8–7.0, is not significantly different
(17.8 
 
6 
 
0.05 mM/pH and 18.79
 
 6 
 
0.04 mM/pH, respec-
tively).
 
The Passive H
 
1
 
 (Equivalent) Permeability of the Golgi 
Complex Is Not Affected by E5
 
M2, a small hydrophobic polypeptide of the influenza vi-
rus, forms a proton pore in the Golgi membrane and
thereby alkalinizes this compartment by inducing H
 
1
 
 leak-
age in excess of H
 
1
 
 pump activity (Sugrue and Hay, 1991;
Pinto et al., 1992). To determine whether the E5 oncopro-
tein increases pH
 
G
 
 by a similar mechanism, we estimated
the passive H
 
1 permeability of the Golgi membrane in
both control and E5-expressing cell lines. This was accom-
plished by measuring the rate of pH change in response to
Figure 3. Effect of concanamycin on pHG and measurement of
buffering power. (A) Resting pHG was measured in control and
E5-transfected cells labeled with FITC-CTB, as described for
Fig. 2. Where indicated, 100 nM concanamycin was added to both
samples. (B) The resting pHG and effect of concanamycin were
measured as in A. Where indicated, the medium was supple-
mented with 10 mM NH4Cl. Data in A and B are representative
of four similar experiments. (Inset) Determinations of buffering
power in control (open bar) and E5-transfected cells (solid bar)
calculated by measuring the DpH induced by a 1-mM NH4Cl
pulse. Data are means 6 SEM of four determinations.The Journal of Cell Biology, Volume 148, 2000 310
an artificially imposed pH gradient. As before, the mea-
surements were performed at the same pH, by pretreating
the cells with concanamycin. The inclusion of the inhibitor
also ensured that the pH changes mediated by the passive
permeability would not be counteracted by the V-ATPase.
To rapidly expose the cytosolic face of the Golgi to media
of varying pH, the plasma membrane was selectively per-
meabilized using streptolysin O. This bacterial toxin binds
to cholesterol and forms pores in the plasma membrane
without altering the integrity of intracellular compart-
ments, which have a considerably lower cholesterol con-
tent. After permeabilization, the external (and therefore
also the cytosolic) pH was suddenly decreased from 7.3 to
5.0 as pHG was monitored continuously (Fig. 4). This re-
sulted in a rapid decrease in pHG, which is indicative of H1
permeability. The initial rate of pHG change was measured
and, because the buffering power is comparable in both
cell types, was taken as a measure of the net H1 flux. In
three experiments, the rate of acidification averaged 0.53 6
0.03 pH/min in control cells and 0.50 6 0.05 pH/min in
cells expressing E5 (Fig. 4 C). These measurements indi-
cate that the passive permeability of the Golgi membrane
to H1 equivalents is not affected by the E5 oncoprotein.
E5 Impairs V-ATPase Activity in the Golgi Complex
Since E5 interacts in vivo with the 16-kD channel-forming
subunit of the V-ATPase (Goldstein and Schlegel, 1990;
Goldstein et al., 1991), we next considered the possibility
that this interaction reduces the activity of the H1 pump.
Because the rates of H1 pumping and leakage are identi-
cal at steady state, V-ATPase activity could in principle be
inferred from the net H1 efflux recorded upon inhibition
with concanamycin. As shown in Fig. 3, only the untrans-
fected cells responded to concanamycin with a sizable al-
kalinization, consistent with the notion that V-ATPase ac-
tivity is reduced in E5-expressing cells. However, the
initial pHG is different for both cell types. At the more al-
kaline pH noted in the E5 transfectants, the gradient driv-
ing the leakage of H1, as well as the proton motive force
opposing the V-ATPase are different. Moreover, inas-
much as concanamycin may not inhibit the pump instanta-
neously, the dissipation of the luminal acid can be influ-
enced by the rate of association with the inhibitor.
To more adequately compare the activity of the control
and E5 cell lines, H1 pumping was assessed at a compara-
ble pH, without using inhibitors. To unmask the activity of
the V-ATPase, pHG was elevated by pulsing the cells with
NH4Cl. To preclude a simultaneous cytosolic alkaliniza-
tion that would alter the pH gradient across the Golgi
membrane, the plasmalemma was initially permeabilized
using streptolysin O. As shown in Fig. 5, A and B, perme-
abilization of the plasma membrane (established indepen-
dently by several criteria) had little effect on pHG, con-
firming the integrity of the Golgi membrane. Addition of
NH4Cl rapidly increased pHG, as a result of preferential
permeation of NH3 and its subsequent protonation. De-
spite the continued presence of the weak base, however, a
rapid reacidification ensued in the case of control (un-
transfected) cells. That this reacidification is mediated by
the V-ATPase is demonstrated in Fig. 5 B, where the cells
were treated with concanamycin before the NH4Cl pulse.
In this case, the secondary acidification phase was lacking
and a sustained alkalinization was recorded.
In contrast, no evidence of V-ATPase activity was found
in the Golgi complex of E5 transfectants. As illustrated in
Fig. 5 C, elevation of pHG in these cells was not followed
by the acute recovery described for the control cells, de-
spite the fact that both cell types were alkalinized to a
comparable degree (pH z7.3). The sustained alkalosis not
only confirms the notion that V-ATPase activity is mini-
mal in the Golgi of cells expressing E5, but also indicates
that the Golgi membrane is comparatively tight to NH4
1.
Rapid permeation of the cationic species would have re-
Figure 4. Estimation of the passive H1 (equivalent) permeability
of the Golgi complex. Control (A) and E5-transfected cells (B)
were labeled with FITC-CTB and used for pHG determinations
as in Fig. 2. Where noted, the plasma membranes were permeabi-
lized by addition of streptolysin O (SLO; 0.25 mg/ml) in perme-
abilization buffer. Next, concanamycin (100 nM) was added to
the medium and finally the bathing solution was replaced for me-
dium of pH 5.0, as pHG was continuously monitored. Data are
representative of four similar experiments. (C) The rates of acid-
ification recorded upon acidification of the medium in experi-
ments like those in A and B were recorded over the initial 20 s.
The rates of control (open bar) and E5-transfected cells (solid
bar) are summarized. Data are means 6 SEM of four experi-
ments.Schapiro et al. E5 Oncoprotein Dissipates Golgi pH 311
stored the original pHG, albeit in a concanamycin-insensi-
tive manner.
The reduced ability of the transfected cells to pump H1
is likely the result of the inhibition of V-ATPase by E5.
Nevertheless, we considered the possibility that the onco-
protein may limit the permeability of the counterions re-
quired to compensate the electrogenic translocation of H1.
In this event, an active V-ATPase would generate a sizable
membrane potential, with little change in pH. This possi-
bility was evaluated by providing an exogenous pathway
for counterion permeation, which would not be antici-
pated to be affected by E5. Cells expressing the oncopro-
tein were incubated with valinomycin, a conductive K1
ionophore that readily reaches intracellular membranes.
Treatment with this ionophore failed to reduce pHG in the
transfectants (not illustrated), suggesting that counterion
conductance was not the factor limiting the activity of the
V-ATPase.
E5 Does Not Alter the V-ATPase Content of the
Golgi Complex
Interaction with E5 may result in mistargeting and/or in-
stability and degradation of the V-ATPases of the Golgi
complex. This could account for the reduced proton
pumping activity described above. This possibility was
tested by quantifying the V-ATPase content of purified
Golgi membranes by immunoblotting, by using an antibody
to its 39-kD subunit, which is firmly membrane-bound and
less likely to detach during purification. Typical results are
shown in Fig. 6. The total cellular content of V-ATPase
was not altered by expression of E5 in NIH-3T3 cells (Fig.
6 A). Similarly, the degree of purification of the final
Golgi preparation was also unaffected by E5, judged by
the enrichment in the Golgi matrix protein GM130 (Fig. 6
B). Most importantly, the V-ATPase content of the Golgi
complex was essentially identical in the control and E5-
transfected cells (Fig. 6, A and B). In three experiments,
V-ATPases were z15-fold enriched in the Golgi com-
pared with the homogenate in both E5 and control cells,
but the Golgi content was not different between them,
whether normalized per protein loaded or per GM130
content.
Correlation between Alteration of pHG and
Cell Transformation
The relationship between Golgi alkalinization and cell
transformation was analyzed using a series of E5 mutants
(Fig. 7 A) that vary in their ability to localize to the Golgi
complex and/or to interact with the V-ATPase. The NIH-
3T3 cell lines expressing the different E5 mutant proteins
are summarized in Table I.
The expression of the mutant forms of E5 in the stable
lines was verified by immunoprecipitation of metabolically
labeled cells, using anti–AU1 antibody. Analysis of the im-
munoprecipitates by SDS-PAGE (Fig. 7 B) indicated that
all mutant cell lines expressed the oncoprotein. The ex-
pression level of all the mutants was not identical, varying
Figure 5. Estimation of the V-ATPase activity in the Golgi com-
plex. (A) Control cells were labeled and permeabilized with
streptolysin O (SLO) as in Fig. 4. Where indicated, NH4Cl (10 mM)
was added and the response was continuously monitored. (B) Af-
ter permeabilization with SLO as in A, the cells were exposed to
concanamycin (CCM; 100 nM). After a steady state was attained,
the cells were pulsed with NH4Cl as above. (C) E5-transfected
cells were labeled and permeabilized with SLO as in A. Where
indicated, NH4Cl (10 mM) was added. Data are means 6 SEM of
four cells from a typical experiment out of four.
Figure 6. Quantitation of the
V-ATPase content of the
Golgi complex. Control (Ctrl)
and E5-transfected cells were
homogenized and used for
purification of the Golgi com-
plex. (A) Samples of the ho-
mogenate and purified Golgi
fractions were analyzed by
SDS-PAGE and blotted with
antibody to the 39-kD sub-
unit of the V-ATPase. Data
are representative of three
similar experiments. (B) Sam-
ples of purified Golgi frac-
tions from control and E5-transfected cells were blotted with anti-
bodies to the Golgi marker GM130 and to the 39-kD subunit of
the V-ATPase (V-39). Two separate experiments are illustrated.The Journal of Cell Biology, Volume 148, 2000 312
from a minimum of 65% of the control (wild-type E5) in
the case of C37S/C39S, to a maximum of 191% for Q17S
(average of three experiments; Fig. 7 B). The observed
variation in E5 electrophoretic mobility is characteristic
for the specific mutation present.
We anticipated that only those forms of E5 that concen-
trate in the Golgi complex would interfere with pHG, ac-
counting for the reported correlation between the ability
of the oncoprotein to localize to the Golgi complex and to
transform cells (Goldstein and Schlegel, 1990; Sparkowski
et al., 1995, 1996). Therefore, we studied the behavior of
two E5 mutants, E5/KDEL and C37S/C39S, which have
altered subcellular targeting. The SEKDEL sequence at-
tached to the COOH terminus of the E5/KDEL protein
contains an ER retention signal. When expressed tran-
siently in COS cells, this mutant has been shown to be de-
fective for cell transformation (Sparkowski et al., 1995). In
stable cell lines, E5/KDEL localized to a reticular, cyto-
plasmic, and perinuclear compartment, consistent with the
ER (Fig. 8). This pattern differed markedly from that of
a-mannosidase II, which was used as a marker of the
Golgi cisternae. The diffuse reticular pattern was also ob-
served for the transformation-defective C37S/C39S E5
mutant. Interestingly, both of these transformation-defec-
tive E5 mutants failed to alkalinize the Golgi (Table I).
This suggests that E5 must directly access the Golgi com-
partment to alter its luminal pH, presumably by binding to
and inhibiting the resident V-ATPase.
However, Golgi localization alone is not sufficient for
E5-mediated transformation. Q17G is a transformation-
defective E5 mutant that translocates to the Golgi com-
plex (Fig. 8 and Table I). Despite being normally localized
and expressed in amounts comparable to the wild-type E5
(88% of control), this mutant does not interfere with Golgi
acidification. Rather, the failure of Q17G to interfere with
V-ATPase function can be explained by its inability to
bind the 16-kD subunit protein.
Figure 7. Expression of E5 mutants in NIH-3T3 transfected cells.
(A) Structure of the E5 oncoprotein, indicating sites of mu-
tations. The proposed transmembrane-spanning region of the
a-helical domain is indicated. (B) Immunoprecipitation of E5
from metabolically labeled NIH-3T3 cells was transfected with
mutant forms of E5, illustrating the amounts of E5 expressed.
The expression levels of the mutants, expressed relative to the
wild-type E5 (100%) are shown below the radiogram. These
numbers are averages of three similar immunoprecipitation ex-
periments.
Table I. 
Cell line
Golgi
localization
PDGFR
activation
Transformed
phenotype pHG
NIH-3T3 NA 22 6.48 6 0.03
wt E5 11 1 6.97 6 0.06
Q17S 12 1 7.04 6 0.05
L26A 12 1 6.96 6 0.04
Q17G 12 2 6.47 6 0.06
C37S/C39S 22 2 6.52 6 0.04
E5/KDEL 21 2 6.49 6 0.02
wt 16-V NA NA 2 6.57 6 0.07
E143R NA NA 1 6.85 6 0.06
NA, not applicable.
Figure 8. Subcellular distribution of mutant forms of E5 in trans-
fected cells. NIH-3T3 cells were stably transfected with epitope-
tagged E5/KDEL (A and B), C37S/C39S (C and D), Q17S (E
and F), Q17G (G and H), and L26A (I and J). The distribution of
the E5 mutants was revealed by labeling with anti–AU1 antibod-
ies (1:800; B, D, F, H, and J), whereas the localization of the
Golgi was assessed by staining with anti–a-mannosidase II anti-
body (1:500; A, C, E, G, and I) as described in Materials and
Methods. Fluorescence images are representative of at least
three experiments of each kind.Schapiro et al. E5 Oncoprotein Dissipates Golgi pH 313
E5 Mutants that Are Defective for Induction of
PDGF-R Autophosphorylation Alkalinize the Golgi 
Compartment and Transform Cells
By using two transformation-competent E5 mutants, Q17S
and L26A, we were able to dissociate the ability of E5 to
induce PDGF-R autophosphorylation and to alkalinize
the Golgi. The Q17S and L26A mutations, which reside in
the E5 transmembrane domain, do not alter the targeting
of E5 to the Golgi complex (Fig. 8). It was previously
shown that the Q17S mutant is unable to induce PDGF-R
autophosphorylation yet retains transforming activity (Spar-
kowski et al., 1994). L26A is also defective for induction of
PDGF-R autophosphorylation, but transforms NIH-3T3
cells with 225% the efficiency of wild-type E5 (Adduci and
Schlegel, 1999). In direct correlation with their retention
of transforming activity, Q17S and L26A were able to al-
kalinize the Golgi (Table I). These results indicate that in-
duction of PDGF-R tyrosine phosphorylation is not the
only mechanism by which E5 can transform cells, and sug-
gests that Golgi alkalinization may also initiate signals for
cell proliferation/transformation.
Golgi Alkalinization Is Not a Consequence
of Transformation
The close correlation between E5-induced transformation
and the elevation of Golgi pH suggests that alkalinization
contributed to the transformation process. However, it is
equally possible that transformation is the cause, and not
the consequence of Golgi alkalinization. This possibility
was tested by measuring pHG in cells transformed by on-
cogenes distinct from E5. Specifically, we measured pHG
in NIH-3T3 cells transfected with oncogenic forms of sis
and src, both of which are components of the PDGF-R sig-
naling pathway. In both cases, the Golgi pH was found to
be acidic pHG 5 6.52 6 0.03 and 6.60 6 0.05 for sis and src
transformants, respectively, similar to that of nontrans-
formed cells. These observations imply that alkalinization
of the Golgi is not an obligatory consequence of cellular
transformation. In addition, while both sis and E5 activate
the PDGF-R, only E5 alkalinizes the Golgi lumen, demon-
strating that receptor activation does not contribute to the
observed changes in Golgi pH.
The Effect of Mutant Forms of V-ATPase on pH
and Transformation
The glutamate residue at position 143 of the 16-kD sub-
unit of the V-ATPase is known to be essential for normal
pump activity (Noumi et al., 1991). Because this glutamate
was also found to be required for interaction with E5, mu-
tants lacking this residue had been tested earlier for trans-
formation. Andresson et al. (1995) found that expression
of a 16-kD subunit harboring the E143R mutation subunit
converted NIH-3T3 cells to an anchorage-independent
state. Therefore, we tested the effect of this mutation on
pHG using CTB and imaging, as detailed in Materials and
Methods. The results are summarized at the bottom of Ta-
ble I. In eight separate experiments, pHG averaged 6.85 6
0.062 in cells expressing the E143R form of the 16-kD sub-
unit, whereas the pH of parallel controls, transfected with
wild-type 16 kD, was 6.57 6 0.07 (n 5 9). Thus, as in E5-
transfected cells, transformation correlated with increased
Golgi pH.
Discussion
PDGF-R–independent Transformation
PDGF-R was the first growth factor receptor to be identi-
fied in a complex with E5 (Petti and DiMaio, 1992), al-
though there was previous evidence that E5 could cooper-
ate with the EGF receptor in the transformation of
fibroblasts (Martin et al., 1989). The close correlation
between PDGF-R activation and fibroblast transforma-
tion by E5 suggested that this association may represent
the sole mechanism for E5-mediated cell transformation.
Later studies suggested that the following alternative
mechanisms may exist: (1) keratinocytes, which lack
PDGF-R, can be converted to the tumorigenic phenotype
by E5 (Leptak et al., 1991); (2) the E5/KDEL mutant pro-
tein induces PDGF-R autophosphorylation but is transfor-
mation-defective (Sparkowski et al., 1995), and (3) some
variants of E5 with mutations in the transmembrane do-
main transform fibroblasts without inducing PDGF-R au-
tophosphorylation (Sparkowski et al., 1996).
The 16-kD subunit of the V-ATPase has also been iden-
tified in a complex with E5 (Goldstein and Schlegel, 1990;
Goldstein et al., 1991), as well as in a ternary complex with
E5 and PDGF-R (Goldstein et al., 1992a). Moreover, a
good correlation exists between the ability of wild-type E5
to transform cells and to bind the 16-kD subunit of the
V-ATPase (Goldstein et al., 1992b; Andresson et al., 1995).
However, the functional significance of this interaction has
never been shown. Although it was hypothesized that E5
might interfere with the acidification of intracellular com-
partments such as endosomes and the Golgi (Goldstein et
al., 1991), early experiments indicated that the BPV E5
protein did not significantly alter endosomal pH (Schlegel,
R., unpublished data) and techniques to directly measure
Golgi pH were unavailable at that time.
Measurement of Golgi pH
Four methods have been used to measure pHG in intact
cells. The earliest method was based on the partition of
weak bases, followed by fixation and detection by immu-
nocytochemical means (Anderson et al., 1984). Subse-
quently, microinjection of pH-sensitive dyes trapped in li-
posomes of defined size was also used to estimate the pH
of the Golgi (Seksek et al., 1995). More recently, an ele-
gant approach using Golgi-targeted green fluorescent pro-
teins was introduced to estimate pHG (Kneen et al., 1998;
Llopis et al., 1998). The method presented here takes ad-
vantage of the retrograde targeting of the B subunit of the
cholera toxin to the Golgi complex. This method is an ex-
tension of the use of verotoxin B, another lipid-binding
bacterial polypeptide that accumulates in the Golgi com-
partment and successfully estimates pHG (Kim et al.,
1996). CTB was the probe of choice in the present study
because NIH-3T3 cells express little globotriaosyl cer-
amide, the receptor for verotoxin. Although quantitative
differences exist, all available determinations of pHG indi-
cate that the Golgi lumen is considerably more acidic thanThe Journal of Cell Biology, Volume 148, 2000 314
the surrounding cytosol. Moreover, both Seksek et al.
(1995) and Kim et al. (1996) found that the acidification
was eliminated by inhibitors of the V-ATPase.
Because E5 has been shown to interact physically with
the 16-kD subunit of the ATPase, we hypothesized that
V-ATPase might display abnormal activity in the Golgi.
Indeed, functional alterations appeared likely, inasmuch
as the site on the 16-kD subunit that interacts with E5, the
glutamic acid residue at position 143, is thought to be es-
sential for the activity of the H1 pump (Noumi et al.,
1991). Our experimental data are consistent with this hy-
pothesis. E5 expression resulted in a marked elevation of
pHG, which was attributable to the inhibition of H1 pump-
ing; no alterations in the buffering capacity or passive H1
permeability of the Golgi were detected. We also ruled out
the possibility that electrogenic pumping was limited by a
lowered counterion conductance. Together, these findings
are most simply explained by the direct inhibition of the
V-ATPase via its physical interaction with E5, without sig-
nificant change in the ATPase content of the Golgi.
It is noteworthy that the human PV-16 E5 protein has
also been demonstrated to bind to the 16-kD subunit of
the V-ATPase (Conrad et al., 1993) and that keratinocytes
expressing the human PV-16 E5 gene have endosomes
with an alkalinized interior (Straight et al., 1995). These
keratinocytes also display inhibition of EGF receptor
turnover, suggesting that interference with receptor degra-
dation may play an important role in the stimulation of ke-
ratinocyte cell growth (Straight et al., 1993). To date, we
have not been able to demonstrate alkalinization of endo-
somes by BPV E5 or to observe any changes in EGF-R
activation. Since the HPV-16 E5 protein also localizes to
the Golgi complex, it will be important to determine
whether it also interferes with the activity of the resident
V-ATPase.
Correlation between pHG and Transforming Activity
Alteration of Golgi pH may provide an alternative mecha-
nism to account for cell transformation in cases where E5
fails to activate the PDGF-R. We have defined two classes
of mutants that dissociate the transforming ability of E5
from PDGF-R activation. The first class is exemplified by
E5/KDEL. This mutant protein induces phosphorylation
of PDGF-R and yet is incapable of transforming cells.
A second class of mutants, including Q17S and L26A,
is capable of transforming cells without phosphorylation
of the PDGF-R. It is possible that E5 triggers signaling
through the PDGF-R in a phosphorylation-independent
manner. In this regard, mutation of the five critical ty-
rosines thought to become phosphorylated and, thereby,
mediate signaling by the PDGF-R, failed to abrogate en-
tirely the induction of immediate early genes (Fambrough
et al., 1999). Alternatively, E5 may promote transforma-
tion by mechanisms that are independent of the PDGF-R.
In this context, alkalinization of the Golgi is an attractive
possibility. Elevating the luminal pH may alter the traffic,
processing, or turnover of mitogenic proteins such as re-
ceptors or kinases, promoting transformation.
The hypothesis linking Golgi pH with transformation
predicts that alkalinization of this organelle by means
other than E5 will produce or at least contribute to trans-
formation. We tested this hypothesis using V-ATPase
inhibitors, ionophores, and weak electrolytes. Unfortu-
nately, prolonged use of these agents, which is required to
assess transformation, resulted in lethality. This likely re-
flects the fact that these treatments affect not only the
Golgi, but all acidic organelles.
V-ATPase activity can alternatively be inhibited by the
expression of competing inactive forms of one or more of
its subunits. As discussed above, the glutamate residue at
position 143 of the 16-kD subunit is essential for normal
pump activity (Noumi et al., 1991). Accordingly, we found
that expression of a mutated form of the 16-kD subunit
(E143R) induced a significant alkalinization of the Golgi
complex (Table I). Two separate clones expressing the
mutant 16-kD subunit were able to transform NIH-3T3
cells, resembling the effects of E5. It is noteworthy that the
transformants expressed only small amounts of mutant
16-kD protein, suggesting that only low-level interference
with the V-ATPase was compatible with cell viability.
Together, these findings point to a correlation between
pHG and the induction of transformation. However, it is
premature to conclude that a causal relationship exists be-
tween these events. Independent and more definitive es-
tablishment of the nature of the relationship will have to
await the development of methods to more selectively ma-
nipulate pHG.
While interaction with the V-ATPase may contribute to
the oncogenic ability of E5, such association is insufficient
to elicit transformation. Several mutants of the human
papillomavirus (Chen et al., 1996), as well as some bovine
papillomavirus mutants (Goldstein et al., 1992b) can bind
to the 16-kD subunit, yet are transformation-defective.
Other effects of E5, distinct from its ability to associate
with the V-ATPase, are needed for effective transforma-
tion.
Possible Effects of Golgi Alkalinization
Perturbation of Golgi acidification could promote trans-
formation and at the same time facilitate viral infection.
For example, alkalinization of the Golgi might induce al-
tered targeting, processing, or turnover of growth factor
receptors or signaling intermediates (protein or lipid),
thereby resulting in a sustained mitogenic stimulation. The
ability of E5 and mutant 16 kD to transform cells is highly
suggestive that Golgi-related events can regulate cell pro-
liferation. In addition to its role in cell transformation, it is
possible that E5 might interfere with antigenic presenta-
tion and help infected host cells evade immune recog-
nition. Finally, it is conceivable that papillomaviruses
disrupt Golgi function to facilitate the development
of koilocytes. These abnormal vacuolated membranous
structures in the Golgi region might facilitate viral release.
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